nference | nference Study Shows Plasma IL-6 Level Can Measure Efficacy of Corticosteroid Treatment for Severe COVID-19 Patients

“Plasma IL-6 levels following corticosteroid therapy as an indicator of ICU length of stay in critically ill COVID-19 patients” published in peer-reviewed Cell Death Discovery Results reveal patients with higher interleukin 6 (IL-6) levels suffer longer ICU stays and greater fatality post-corticosteroid treatment Report indicates significance of IL-6 testing as a biomarker for COVID-19 severity.

nference Study Shows Plasma IL-6 Level Can Measure Efficacy of Corticosteroid Treatment for Severe COVID-19 Patients